Certara to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Certara (Nasdaq: CERT), a global leader in model-informed drug development, has announced its participation in two major upcoming investor conferences in 2025.
The company will present at:
- BofA Securities Healthcare Conference on Tuesday, May 13 at 3:40 p.m. PT
- William Blair Growth Stock Conference on Wednesday, June 4 at 12:40 p.m. CT
Investors and interested parties can access live webcasts of both presentations through Certara's investor relations website at ir.certara.com. The recordings will remain available for replay for at least 90 days after the events.
Positive
- Active participation in major healthcare investor conferences (BofA Securities and William Blair) indicates strong institutional investor relations
- Live webcasts with 90-day replay availability demonstrates transparency and accessibility for investors
Negative
- None.
RADNOR, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences:
- BofA Securities 2025 Healthcare Conference
Date and Time: Tuesday, May 13 at 3:40 p.m. PT
- William Blair 45th Annual Growth Stock Conference
Date and Time: Wednesday, June 4 at 12:40 p.m. CT
Live webcasts for each of the conferences will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.
About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.
Investor Relations Contact:
David Deuchler
Gilmartin Group
ir@certara.com
Media Contact:
Alyssa Horowitz
certara@pancomm.com